CPC C07D 471/04 (2013.01) | 21 Claims |
1. A pharmaceutical composition comprising a pharmaceutically acceptable carrier and a compound represented by Formula I:
or a pharmaceutically acceptable salt thereof, wherein
R1 is selected from the group consisting of —CR2R3R4, a monocyclic C3-6 cycloalkyl, and a 4- to 7-membered monocyclic heterocyclyl, wherein said cycloalkyl and heterocyclyl are optionally substituted with one or more Ra;
R2 is a C1-4 haloalkyl or a monocyclic C3-6 cycloalkyl optionally substituted with one or more Rb;
R3 is selected from the group consisting of hydrogen, a C1-4 alkyl, and a C1-4 haloalkyl;
R4 is selected from the group consisting of hydrogen, a C1-4 alkyl, and a C1-4 haloalkyl;
R5 is a halogen;
R6 is a C1-4 haloalkyl or a C3-6 monocyclic cycloalkyl, wherein said cycloalkyl is optionally substituted with one or more Rc;
t is 1 or 2; and
Ra, Rb, and Rc are each independently selected from the group consisting of a halogen, a C1-4 alkyl, a C1-4 haloalkyl, a C1-4 alkoxy, and a C1-4 haloalkoxy, wherein the pharmaceutical composition is in a unit dosage form.
|